• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

    5/19/25 8:44:53 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary
    Get the next $MRM alert in real time by email

    TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM") today announced that it will host a webcast to review the Company's financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time.

    The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company's financial results for the 2024 fiscal year and is available on the Securities and Exchange Commission website at www.sec.gov.

    To access the webcast, please go to the following URL five to ten minutes prior to its start:

    https://event.choruscall.com/mediaframe/webcast.html?webcastid=9rHZ3uFf

    To participate in the webcast, please use the following dial-in numbers:

    North America (toll free):1-844-413-3971
    International:1-412-317-5775
    Japan (toll-free):0066-33-1-33094

    Conference Replay:

    A replay of this call will be available on May 21, 2025 at 11:30 a.m. ET until June 4, 2025, at 11:59 PM ET.

    To access the replay, please dial:

    US (toll free): 1-877-344-7529
    International (toll): 1-412-317-0088
    Canada (toll free):855-669-9658
    Replay Access Code: 9951136

    To access the replay using an international dial-in number, please select the following link:



    https://services.choruscall.com/ccforms/replay.html



    About MEDIROM Healthcare Technologies Inc.



    MEDIROM, a holistic healthcare company, operates 307 (as of March 31, 2025) relaxation salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called "Lav®", which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker "MOTHER Bracelet®". In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en.



    Forward-Looking Statements



    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:

    • the Company's ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
    • the Company's ability to sell certain of its owned salons to investors, and receive management fees from such sold salons, on acceptable terms;
    • changes in Japanese and global economic conditions and financial markets, including their effects on the Company's expansion in Japan and certain overseas markets;
    • the Company's ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
    • the fluctuation of foreign exchange rates, which affects the Company's expenses and liabilities payable in foreign currencies;
    • the Company's ability to hire and train a sufficient number of therapists and place them at salons in need of additional staffing;
    • changes in demographic, unemployment, economic, regulatory or weather conditions affecting the Tokyo region of Japan, where the Company's relaxation salon base is geographically concentrated;
    • the Company's ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
    • the financial performance of the Company's franchisees and the Company's limited control with respect to their operations;
    • the Company's ability to raise additional capital on acceptable terms or at all;
    • the Company's level of indebtedness and potential restrictions on the Company under the Company's debt instruments;
    • changes in consumer preferences and the Company's competitive environment;
    • the Company's ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
    • the regulatory environment in which the Company operates.

    More information on these risks and other potential factors that could affect the Company's business, reputation, results of operations, financial condition, and stock price is included in the Company's filings with the SEC, including in the "Risk Factors" and "Operating and Financial Review and Prospects" sections of the Company's most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. The Company assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.



    Contact:

    Investor Relations Team

    [email protected]



    Primary Logo

    Get the next $MRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MRM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MRM
    SEC Filings

    View All

    SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

    6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

    2/3/26 9:08:15 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

    6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

    1/30/26 6:57:57 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

    6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

    1/23/26 4:30:16 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

    TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:NASDAQ, hereinafter "MEDIROM"), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the "MSA") with Tools for Humanity ("TFH") and the World Foundation ("WF"), and will support World ID adoption with the installation of Orbs across 3,000 locations nationwide in Japan. Tools for Humanity was co-founded by Sam Altman and Alex Blania and led the initial development of the World Project. The Orb is a device that allows an individual to verify that they are a unique human, and create a secure an

    1/23/26 5:00:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku's "Orb" Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months

    TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), announces that the cumulative number of Proof of Human authentications using the World ID authentication device ‘Orb' at stores centered on the relaxation salon "Re.Ra.Ku," operated by its subsidiary MEDIROM Wellness Co., surpassed 20,000 as of December 28, 2025. The Company participates in World (a Proof of Human authentication protocol), co-founded by Sam Altman and Alex Blania, and is advancing access to Proof of Human technology via the World Network. This milestone of surpassing 20,000 verifications represents a do

    1/8/26 4:15:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying "Proof of Human" Infrastructure throughout Japan

    TOKYO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), a diversified healthcare company, collaborating with World Foundation and Tools for Humanity to deploy Proof of Human technologies such as World ID throughout Japan. The World project was co-created by Sam Altman and Alex Blania. In preparation for the full-scale rollout of the World project in Japan, MEDIROM has entered into a Master Service Agreement ("MSA") with Tools for Humanity ("TFH") and World Foundation ("WF"). Under the MSA, the MEDIROM Group will be responsible for the operation of "Proof of Human" verification

    12/29/25 8:18:48 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Leadership Updates

    Live Leadership Updates

    View All

    "NASDAQ JAPAN IR EVENT" to Be Held at Nasdaq MarketSite on June 20, 2024

    NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor

    5/20/24 3:00:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Financials

    Live finance-specific insights

    View All

    MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y's, Inc.

    TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to

    10/7/24 4:00:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023

    TOKYO, June 25, 2024 (GLOBE NEWSWIRE) --  MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel

    6/25/24 9:37:44 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    MEDIROM Healthcare Technologies Inc. Announces Preliminary 2021 Financial Results

    NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o

    5/13/22 7:53:59 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by MEDIROM Healthcare Technologies Inc.

    SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

    12/10/24 7:38:12 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

    SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

    1/25/23 4:16:06 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

    SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

    1/6/23 6:12:19 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary